YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
AMIE is Google’s research program for AI-assisted medical dialogue, reasoning and care interactions, including multimodal and longitudinal research. Bagoodex’s former site now directs visitors to Sigma’s hosted AI chat service. Ratings are subjective editorial opinions for each product’s stated purpose, not measured benchmarks.
Bagoodex’s former site now directs visitors to Sigma’s hosted AI chat service. The current destination is a browser chat application. Historical Bagoodex search claims should not be assumed to describe every capability of Sigma Chat.
AMIE is Google’s research program for AI-assisted medical dialogue, reasoning and care interactions, including multimodal and longitudinal research. The research covers diagnostic conversation, images, real-time video and longer-term care scenarios. Clinical feasibility studies extend earlier simulated evaluations, but the system remains research rather than an independently practising clinician.
These scores express our judgement of the cited product facts. They are not measured performance benchmarks. Each product is assessed for its stated purpose; a higher score does not make different workflows interchangeable.
Evidence gaps lower confidence and affect the relevant judgement. Unknown pricing does not mean free access. Research prototypes and retired products retain their historical scope, with adoption ratings reflecting current access.
Ratings assessed: 2026-11-07. Source verification dates may differ.
Documented capability: How useful and complete is the documented workflow for the product's stated purpose?
Ease of adoption: Can the intended user obtain and set up a usable product today?
Value and cost clarity: How attractive and understandable is the cost model for the documented use?
Integration options: How useful and extensible are the verified user-facing connections for the intended workflow?
AMIE: 6/10
Evidence confidence: high
The research covers diagnostic conversation, images, real-time video and longer-term care scenarios. Clinical feasibility studies extend earlier simulated evaluations, but the system remains research rather than an independently practising clinician.
Bagoodex: 5/10
Evidence confidence: medium
The current destination is a browser chat application. Historical Bagoodex search claims should not be assumed to describe every capability of Sigma Chat.
The scores judge completeness for each stated purpose; different workflows are not interchangeable.
AMIE: 2/10
Evidence confidence: high
Access is through research studies and collaborations. There is no ordinary patient or clinician self-service deployment path in the published project materials.
Bagoodex: 7/10
Evidence confidence: medium
The redirect provides a live browser entry point, but account access and the selected chat offer determine the usable features.
Access, setup and human responsibilities matter alongside features.
AMIE: 2/10
Evidence confidence: high
No generally purchasable AMIE subscription or clinical software price is published. Research results do not establish a current consumer offer.
Bagoodex: 4/10
Evidence confidence: medium
Current account terms need checking at the Sigma destination; old Bagoodex pricing is not a reliable purchase guide.
Compare the full cost of your intended workflow, including external services and implementation.
AMIE: 2/10
Evidence confidence: high
Multimodal research inputs are not evidence of a public EHR, Teams or developer API integration. Clinical workflow connections depend on the study setting.
Bagoodex: 2/10
Evidence confidence: medium
A hosted chat interface is established, but a public automation API or broad native connector set is not established for this destination.
Choose the connections your workflow needs, rather than counting partner logos.
Follow AMIE for medical AI research; use established care services for personal medical decisions and clinical deployment needs.
Follow the current Sigma destination if you want general chat, and check its current account terms. It is not a medical or drug-design system.
YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS
Give businesses AI teams that own ongoing roles. Set your pricing, delegate routine coordination and build a recurring service.